Oxidative damage to DNA can lead to tumor development; in that case, selenoproteins can decrease the risk of CRC [157], so selenium and selenoproteins can be used as chemoprotective agents, since selenium is involved in regulating apoptosis and proliferation of the intestinal epithelium [153]. The gene discussed is SELENOS; the disease is neoplasm.